Terumo (OTCMKTS:TRUMY) Shares Gap Up – Still a Buy?

Terumo Corp. (OTCMKTS:TRUMY) gapped up before the market opened on Tuesday . The stock had previously closed at $13.25, but opened at $13.9601. Terumo shares last traded at $13.98, with a volume of 39,095 shares changing hands.

Analyst Upgrades and Downgrades

Separately, Zacks Research raised Terumo to a “hold” rating in a report on Thursday, April 9th. Two investment analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, Terumo has a consensus rating of “Hold”.

Terumo Stock Up 2.6%

The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.97 and a current ratio of 1.59. The firm has a market capitalization of $20.71 billion, a PE ratio of 23.02 and a beta of 0.68. The company has a fifty day moving average price of $14.01 and a 200-day moving average price of $13.53.

Terumo (OTCMKTS:TRUMY) last posted its earnings results on Friday, May 15th. The company reported $0.11 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.11. Terumo had a net margin of 12.09% and a return on equity of 9.17%. The firm had revenue of $1.90 billion during the quarter, compared to analyst estimates of $1.84 billion. As a group, analysts expect that Terumo Corp. will post 0.7 earnings per share for the current year.

Terumo Company Profile

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.